22 December 2023
Conference "Dietary Supplements for Osteoporosis: OSTEOME Study"
The conference “Dietary Supplements for Osteoporosis: OSTEOME Study” was successfully completed...
11 December 2023
Participation in the MedChem 2023 Conference in Brussels, Belgium
Cloudpharm participated at the MedChem 2023 Conference in Brussels, Belgium, on December 8, 2023. Hosted...
07 December 2023
Invitation to the Seminar "Dietary Supplements for Osteoporosis: OSTEOME Study"
You are cordially invited to participate in the live seminar “Dietary Supplements for Osteoporosis:...
05 December 2023
Participation at the 73rd HUSBMB conference
We are glad to announce that the OSTEOME’s project partner “Cloudpharm” has participated in the 73rd...
11 November 2023
Successful Completion of Webinars on OSTEOME Project Findings!
We are thrilled to announce the successful completion of our recent webinars held on November 15 and...
08 November 2023
Webinar Invitation: Exploring Microbiome-Bone Relationship in Osteoporosis Management - OSTEOME Project Findings
We invite you to participate in the webinars on Wednesday, November 15, 2023, and Monday, November 20,...
06 November 2023
Invitation to the webinar “Design of dietary supplements with computational chemistry tools. The case of osteopenia."
Wednesday, 22 November 2023 |12:00 – 13:00 Cloudpharm invites you to the webinar entitled “Design...
06 November 2023
Participation in the 30th Panellenic Conference the Hellenic Society for the Study of Bone Metabolism (H.S.S.B.M.)
We are glad to announce that members of the research team from the OSTEOME project at the NKUA –...
06 November 2023
Educational webinars for patients entitled as “Love Your Bones” and “You Ask, We Answer!”
The Butterfly Bone Health Society organized several educational webinars aimed to spread awareness about...
11 October 2023
Participation in the 79th conference of the Hellenic Society of Orthopaedic Surgery and Traumatology (HSOST)
On October 4-7, 2023, in Athens, the research team of the NKUA – participated in the 79th...
02 October 2023
Participation in the 16th Annual Bone Health Conference, 30/9/2023, Divani Caravel Hotel
At the 16th Annual Bone Health Conference held on Saturday 30/9/2023 at the Divani Caravel Hotel, and...
25 September 2023
Participation in the InnoHealth Forum Exhibition
The project team of CLOUDPHARM participated in the InnoHealth Forum Exhibition, which took place from...
21 September 2023
Participation of the National Hellenic Research Foundation in the IMA-2023 Conference
From September 17th to 20th, members of the research team of the NHRF participated in the 13th International...
19 September 2023
Cloudpharm presents OSTEOME Project Results at 1st Bio3 Forum Conference in Athens
From September 15 to 18, 2023, the 1st Bio3 Forum conference took place in Athens, where the results...
26 July 2023
Participation in the MedChem2023 XII Meeting of the Paul Ehrlich Euro – PhD Network
Cloudpharm showcased its most recent advancements at the MEDCHEM 2023 conference in Thessaloniki, Greece,...
16 May 2023
Participation in the International Summit On Biopolymers And Polymer Science (ISBPS2023)
On May 12, 2023, part of the OSTEOME project’s research was presented through a poster presentation...
14 March 2023
Participation in the 19th Hellenic Symposium on Medicinal Chemistry (HSMC 19)
CLOUDPHARM, a key contributor to the OSTEOME project (T2EDK-03847), actively participated in the 19th...
21 October 2022
PARTICIPATION IN THE 15TH ANNUAL SKELETAL HEALTH CONFERENCE
On October 15th 2022, the «Butterfly» Bone Health Society organized the 15th annual Skeletal Health Conference...
11 October 2022
PARTICIPATION IN BEYOND EXPO 2022
CLOUDPHARM‘s project team participated in the BEYOND Innovation and Technology Exhibition, which took...
29 June 2022
Information and Awareness Seminars on Osteoporosis and the Osteome Research Program
The Butterfly Bone Health Society organized a series of events across the Attica region, aiming to inform...
30 May 2022
OPEN INVITATION TO PARTICIPATE FOR 200 POSTMENOPAUSAL WOMEN WITH OSTEOPENIA
Within the framework of OSTEOME research project, volunteers intersted in participating in the clinical...
14 May 2022
One-day Conference for osteoporosis and the microbiome, University of West Attica, 13th May 2022
On May, 13th, 2022, an informative event was held for the staff and students of the University of West...
14 May 2022
CONFERENCE “OSTEOPOROSIS AND FRACTURE RISK”
The research project OSTEOME, was presented at the conference “OSTEOPOROSIS AND FRACTURE RISK” co-organized...
15 April 2022
EFFECTS OF NON-POLAR DIETARY AND ENDOGENOUS LIPIDS ON GUT MICROBIOTA ALTERATIONS: THE ROLE OF LIPIDOMICS
Advances in sequencing technologies over the past 15 years have led to a substantially greater appreciation...
12 April 2022
Exciting News: OSTEOME Project's Paper Published!
We are glad to announce the publication of the OSTEOME project team’s paper titled “Effects...
06 April 2022
ROLE OF THE MICROBIOME IN REGULATING BONE METABOLISM AND SUSCEPTIBILITY TO OSTEOPOROSIS
The human microbiota functions at the interface between diet, medication-use, lifestyle, host immune...
03 December 2021
HESPERIDIN PROMOTES OSTEOGENESIS AND MODULATES COLLAGEN MATRIX ORGANIZATION AND MINERALIZATION IN VITRO AND IN VIVO
This study evaluated the direct effect of a phytochemical, hesperidin, on pre-osteoblast cell function...
09 November 2021
NATURAL PRODUCTS FOR TREATMENT OF OSTEOPOROSIS: THE EFFECTS AND MECHANISMS ON PROMOTING OSTEOBLAST-MEDIATED BONE FORMATION
Osteoporosis is a systemic metabolic bone disease characterized by a reduction in bone mass, bone quality,...
28 September 2021
MICROBIAL OSTEOPOROSIS: THE INTERPLAY BETWEEN THE GUT MICROBIOTA AND BONES VIA HOST METABOLISM AND IMMUNITY
The complex relationship between intestinal microbiota and host is a novel field in recent years. A large...
30 August 2021
GUT MICROBIOME AND OSTEOPOROSIS
Osteoporosis (OP) is a chronic metabolic bone disease characterized by the decrease of bone tissue per...
12 August 2021
BOTANICALS IN POSTMENOPAUSAL OSTEOPOROSIS
Osteoporosis is a systemic bone disease characterized by reduced bone mass and the deterioration of bone...
23 July 2021
THE GUT MICROBIOME IS ALTERED IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND OSTEOPENIA
Osteoporosis and its precursor osteopenia are common metabolic bone diseases in postmenopausal women....